Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Backgrounder
Biosimilars Bulletin
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Media
Member Spotlight
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video
Whitepapers

Resources

Patients Increasingly Rely on Oncology Biosimilar Medicines
October 28, 2021
AAM Annual Savings Report - Biosimilars and Bending the Cost Curve
October 14, 2021
patient access to biosimilars
Increase Patient Access to Lower-Cost Biosimilar Medicines
July 27, 2021
The Biosimilars Council - Doctors with hands in the middle
Organizations Thank Rep. Schrader, Kinzinger for Introducing the BIOSIM Act
July 1, 2021
Increasing Provider Reimbursement for Biosimilars Will Lead to Greater Adoption
June 28, 2021
Biosimilar Medicines Equal More Accessible Care for America’s Patients
June 11, 2021

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

Recent Tweets

Biosimilars CouncilFollow2,15610,190

Biosimilars Council works to ensure a positive environment for patient access to biosimilar medicines. Division of @AccessibleMeds | https://t.co/0jAeG0TOPj

Biosimilars Council
BiosimsCouncil avatarBiosimilars Council@BiosimsCouncil·
9h 1466166578232320001

Build Back Better aims to reduce drug prices, but its short-term solution would only damage the #biosimilars industry in the long run and reduce access for America's patients.

Learn more to see how this bill could undermine patients' access to care: https://bit.ly/2ZyFYFA

Twitter feed video.
Image for the Tweet beginning: Build Back Better aims to
Reply on Twitter 1466166578232320001Retweet on Twitter 1466166578232320001Like on Twitter 1466166578232320001Twitter 1466166578232320001
Load More...